Blood-based biomarkers offer a promising, minimally invasive approach to Alzheimer’s disease (AD) diagnosis, yet validation in admixed populations remains limited. We investigated whether plasma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results